Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Rapp

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Cancer Research|May 1, 1979
Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oilE Yarkoni, H J Rapp
Tierarztliche Praxis. Supplement|January 1, 1993
[Ultrasonic studies of newborn foals]S L Spurlock, H J Rapp
The Medical Clinics of North America|May 1, 1976
Intralesional immunotherapy of melanoma with BCGS A Rosenberg, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1973
The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activationM Loos, T Borsos, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1972
Activation of the first component of complement evidence for an internal activation stepM Loos, T Borsos, H J Rapp
Infection and Immunity|April 1, 1981
Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolateE Yarkoni, E Lederer, H J Rapp
Cancer|December 1, 1977
Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally activeB Zbar, E Ribi, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1972
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. IV. Formation of EAC42 by treatment of C2 with trypsin in the presence of EAC4M Loos, T Borsos, H J Rapp
National Cancer Institute Monograph|December 1, 1973
An experimental model for immunotherapy of cancerB Zbar, E Ribi, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cellsB Detrick-Hooks, T Borsos, H J Rapp
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Cancer Research|May 1, 1979
Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oilE Yarkoni, H J Rapp
Tierarztliche Praxis. Supplement|January 1, 1993
[Ultrasonic studies of newborn foals]S L Spurlock, H J Rapp
The Medical Clinics of North America|May 1, 1976
Intralesional immunotherapy of melanoma with BCGS A Rosenberg, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1973
The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activationM Loos, T Borsos, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1972
Activation of the first component of complement evidence for an internal activation stepM Loos, T Borsos, H J Rapp
Infection and Immunity|April 1, 1981
Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolateE Yarkoni, E Lederer, H J Rapp
Cancer|December 1, 1977
Immunotherapy of a guinea pig hepatoma with living BCG: a frozen liquid and a lyophilized preparation are equally activeB Zbar, E Ribi, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1972
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. IV. Formation of EAC42 by treatment of C2 with trypsin in the presence of EAC4M Loos, T Borsos, H J Rapp
National Cancer Institute Monograph|December 1, 1973
An experimental model for immunotherapy of cancerB Zbar, E Ribi, H J Rapp
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cellsB Detrick-Hooks, T Borsos, H J Rapp
Pageof 15